viewAviva plc

Aviva disappoints with decision not to sell Chinese business

The FTSE 100 insurer said retaining the business would provide the most value for shareholders, however, it is still considering options for its operations in Hong Kong, Vietnam and Indonesia

Aviva plc - Aviva decides against sale of Singapore and Chinese businesses
Aviva said back in August that it was considering an exit from Asia

Aviva PLC (LON:AV.) has decided against selling off its businesses in China and Singapore, sending its share lower.

Following a review of its Asian businesses, the FTSE 100 life insurer said on Monday that it was still looking at options for its businesses in Hong Kong, Vietnam and Indonesia but had decided that retaining its business in Singapore will achieve “the best value for shareholders”.

READ: Aviva weighs Asian exit as life and asset management toil in first half

Aviva will also be maintaining its joint venture in China with the state-backed China National Cereals, Oils and Foodstuffs Corporation, citing the scale of the market and “high growth prospects”.

“Aviva's Singapore and China business units delivered double digit operating profit growth in 2018 and are earning attractive returns. Both countries are expected to pay dividends to group centre in 2019,” the company said.

Aviva revealed in August that it was mulling several possibilities for its Asian operations, including a possible sale.

This followed a mixed set of first-half results which saw profits from its core life insurance arm decline 8% to £1.3bn while those from general insurance were up 29% to £391mln.

The news drove the shares 3.5% lower to 419.4p in early deals.

Quick facts: Aviva plc

Price: 279.9 GBX

Market: LSE
Market Cap: £10.99 billion

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...


GinsGlobal Managing Director sees Healthcare and Healthcare innovation as...

HANetf and GinsGlobal Index Funds' Managing Director Anthony Ginsberg joined Steve Darling from Proactive to share details about the success of their Healthcare Innovations ETF. Ginsberg discusses how COVID-19 had made a direct impact on that fund, especially in the telemedicine...

19 hours, 36 minutes ago

2 min read